Decoding tumor-induced senescence: ex vivo insights from neoadjuvant chemotherapy in high-grade serous ovarian cancer

被引:0
|
作者
Giglioni, Claudia [1 ]
Barsanti, Federica [1 ]
Orlandi, Gretha [1 ]
Magherini, Francesca [1 ]
Taddei, Maria Letizia [1 ]
Farsi, Elisa [1 ]
Fambrini, Massimiliano [1 ]
Sorbi, Flavia [1 ]
机构
[1] Univ Florence, Div Obstet & Gynecol, Dept Biomed Expt & Clin Sci, Florence, Italy
关键词
D O I
10.1136/ijgc-2024-ESGO.668
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
544
引用
收藏
页码:A341 / A342
页数:2
相关论文
共 50 条
  • [21] Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
    Elorbany, Samar
    Berlato, Chiara
    Carnevalli, Larissa S.
    Maniati, Eleni
    Barry, Simon T.
    Wang, Jun
    Manchanda, Ranjit
    Kzhyshkowska, Julia
    Balkwill, Frances
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [22] Single-cell spatial dynamics of the tumor-immune microenvironment of high-grade serous ovarian cancer during neoadjuvant chemotherapy
    Launonen, Inga-Maria Pauliina
    Szabo, Angela
    Perez, Fernando
    Casado, Julia
    Maliga, Zoltan
    Hautaniemi, Sampsa
    Oikkonen, Jaana
    Hynninen, Johanna
    Vallius, Tuulia
    Nirmal, Ajit Johnson
    Sorger, Peter
    Vaharautio, Anna
    Farkkila, Anniina
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro
    Paweł Uruski
    Agnieszka Sepetowska
    Corinna Konieczna
    Martyna Pakuła
    Michał Wyrwa
    Akylbek Tussupkaliyev
    Andrzej Tykarski
    Justyna Mikuła-Pietrasik
    Krzysztof Książek
    Cellular & Molecular Biology Letters, 2021, 26
  • [24] Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro
    Uruski, Pawel
    Sepetowska, Agnieszka
    Konieczna, Corinna
    Pakula, Martyna
    Wyrwa, Michal
    Tussupkaliyev, Akylbek
    Tykarski, Andrzej
    Mikula-Pietrasik, Justyna
    Ksiazek, Krzysztof
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2021, 26 (01)
  • [25] Role of tumor location on high-grade serous ovarian cancer prognosis
    Ay, Seval
    Ozyukseler, Deniz Tataroglu
    Basak, Mustafa
    Dulgar, Ozgecan
    Arici, Serdar
    Yildirim, Mahmut Emre
    Gumus, Mahmut
    GINEKOLOGIA POLSKA, 2022, 93 (04) : 284 - 289
  • [26] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer
    Xia Xu
    Fei Deng
    Mengmeng Lv
    Xiaoxiang Chen
    Archives of Gynecology and Obstetrics, 2017, 295 : 451 - 458
  • [28] Ovarian Cancer Response Scoring (OCRS): Validation of a system to quantify histopathological response to neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Singh, N.
    Said, I.
    Faruqi, A.
    Gilks, B.
    Le, N.
    Boehm, S.
    VIRCHOWS ARCHIV, 2014, 465 : S40 - S40
  • [29] Predicting Neoadjuvant Chemotherapy Response and High-Grade Serous Ovarian Cancer From CT Images in Ovarian Cancer with Multitask Deep Learning: A Multicenter Study
    Yin, Rui
    Guo, Yijun
    Wang, Yanyan
    Zhang, Qian
    Dou, Zhaoxiang
    Wang, Yigeng
    Qi, Lisha
    Chen, Ying
    Zhang, Chao
    Li, Huiyang
    Jian, Xiqi
    Ma, Wenjuan
    ACADEMIC RADIOLOGY, 2023, 30 : S192 - S201
  • [30] Neoadjuvant Chemotherapy for Tubo-ovarian High-grade Serous Carcinoma: Correlation of Clinical Response with Tumor Morphology and Immunophenotype
    Liu, Yuxin
    Schwartz, Melissa
    Kalir, Tamara
    MODERN PATHOLOGY, 2018, 31 : 436 - 436